Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma

H Iida ¹, M Honda , H F Kawai

⁰Department of Cancer Gene Regulation, Kanazawa University Graduate School of Medical Science, 13-1 Takara-Machi, Kanazawa 920-8641, Japan.

Gut +

|

May 13, 2005

View abstract on PubMed

Summary

Ephrin-A1 is overexpressed in hepatocellular carcinoma (HCC) and drives tumor growth and spread. This angiogenic factor significantly correlates with alpha-fetoprotein (AFP) levels, impacting patient prognosis.

Area Of Science

Oncology
Molecular Biology
Hepatology

Background

Alpha-fetoprotein (AFP) is a tumor marker for hepatocellular carcinoma (HCC) associated with poor prognosis.
Ephrin-A1, an angiogenic factor, was previously identified as the most differentially overexpressed gene in AFP-producing HCC cell lines.

Purpose Of The Study

To investigate the significance of ephrin-A1 expression in HCC.
To determine the role of ephrin-A1 in HCC cell proliferation, gene expression, and AFP induction.

Main Methods

Examined ephrin-A1 expression in hepatoma cell lines and human HCC specimens.
Assessed the effects of ephrin-A1 on cell proliferation using cell lines with varying ephrin-A1 expression.
Utilized cDNA microarray analysis to identify ephrin-A1-induced genes.

Main Results

Ephrin-A1 expression was significantly elevated in HCC tissues compared to normal and cirrhotic liver.
Ephrin-A1 expression strongly correlated with AFP levels and was shown to induce AFP expression.
Ephrin-A1 promoted hepatoma cell proliferation and induced genes involved in cell cycle, angiogenesis, and cell-cell interactions.

Conclusions

Ephrin-A1 contributes to the poor prognosis of AFP-producing HCC by inducing genes related to tumor growth, angiogenesis, invasion, and metastasis.
Ephrin-A1 plays a critical role in the pathogenesis and progression of HCC.

Related Concept Videos